Page 9 - Highlights of Napcon 2021

CONTENTS

1. Newer Technology in OSA Management ........ 11 19. Fungal Infections in Chronic Lung Diseases... 29
Dr. Abhinav Chaudhary Dr. Chandrakant Tarke

2. Preventive Approach in Management of Chronic 20. Personalized Management of Lung Cancer .... 30
Respirator y Diseases: Importance of Vaccines.. 12 Dr. D Behera
Dr. Agam Vora
21. Pulmonar y Leptospirosis:
3. New ATS/IDSA Community-Acquired How Do I (Should I) Deal with It? ................. 31
Pneumonia Guideline: More Micro, Less Dr. D Ganguly
Macrolide, No HCAP ................................... 13
Dr. Ajeet Singh 22. Antibiotic Resistance in Upcoming Decade .... 32
Dr. Debraj Jash
4. Glucocorticoids and Anti-thrombotic Agents in
COVID-19: Which One, How Long?................14 23. Anticoagulants in COVID-19 ........................ 33
Dr. Alok Nath Dr. Deepak Muthreja

5. Thrombolysis and Surger y in PE: 24. How to Choose Biologics: Which? ................ 34
When and Why? ........................................ 15 Dr. Deepak Talwar
Dr. Amina Mobashir
25. Complex Sleep Apnea - Is it Complex? .......... 35
6. Screening for Sleep Disordered Breathing ..... 16 Dr. Dhrubajyoti Roy
Dr. Anand Kumar
26. Pulmonar y Medicine:
7. Hepatic Hydrothorax ....................................17 Evolution of a Specialty & Challenges ........... 36
Dr. Anirban Sarkar Dr. Dhruva Choudhary

8. Radiotherapy in Lung Cancer ........................18 27. Pulmonar y Renal Syndrome ......................... 37
Dr. Ankita Patel Dr. Dipti Gothi

9. Lifestyle Modifications in Asthma ................. 19 28. HFNC Versus NIV in COVID Hypoxia ............38
Dr. Arun Chowdary Kotaru Dr. Divya R, Dr. Trinath Dash

10. Is NIV Useful in All Forms of 29. Drug-resistant TB: Who and Why? ................ 39
Acute Respirator y Failure? .......................... 20 Dr. G N Srivastava
Dr. Ashok Kumar Singh, Dr. Irfan Ismail Ayub
30. Issues Related to Post-Covid Fibrosis ........... 40
11. Machine Perfusion & The Future of Dr. G C Khilnani
Lung Transplants ........................................ 21
Dr. Attawar Sandeep 31. Rheumatoid Lung ........................................ 41
Dr. Girish Sindhwani
12. Macrolides in Adults with Respiratory Diseases .. 22
Dr. Atul Luhadia 32. What is New? GINA 2021 ............................ 42
Dr. Harjit Dumra
13. Scleroderma ILD ........................................ 23
Dr. B P Singh 33. Drug-Resistant TB and Pregnancy ............... 44
Dr. Jai Kishan
14. Medical Thoracoscopy and Its Evolving Role
in the Management of Pleural Diseases ........ 24 34. Prevention of Infections in ICU ................... 45
Dr. Balamugesh T Dr. Jefferson Daniel

15. Assessment, Prognosis and Guideline 35. WHO Global Air Quality Guidelines 2021 ..... 46
Implementation in Pulmonar y Arterial Dr. Kalpana Balakrishnan
Hypertension .............................................. 25
Dr. Bhagwan Mantri 36. Ebus Guided Cr yobiopsy ............................ 47
Dr. Karan Madan
16. How are New Global Guidelines Helping
Treatment of My Patients Differently? ........... 26 37. New Drugs (Biologics) for Asthma ............... 48
Dr. Bharat Bhushan Sharma Dr. Kumari Indira K S

17. Non-Pharmacological Strategies in 38. COPD: New Clinical and RWE Data on
Bronchial Asthma ....................................... 27 Treatment Choices ...................................... 49
Dr. C R Choudhary Dr. Lancelot Pinto

18. Newer Molecules in PAH ............................. 28 39. Drug Resistant: Pulmonary Infections in ICU... 50
Dr. Chakrahari Ugandhar Bhattu Dr. Loganathan N

Highlights of NAPCON 2021 7